TRAUMA: Fresh frozen plasma-first approach is independently associated with improved survival in severely injured patients undergoing massive transfusion

02.08.26

Allyson M Hynes, Riley J Westein, Tyler J Turner, Ryan D Conrardy, Kai Yang, Kelly A Boyle, Jeremy H Levin, Marc A de Moya

PMID: 42275580
DOI: 10.1097/TA.0000000000005093

Abstract

Background: Despite evidence supporting high fresh frozen plasma (FFP)-to-packed red blood cell (PRBC) ratios, the optimal initial blood product in severe injury is unknown. We hypothesized that an FFP-first approach is associated with improved survival.

Methods: An observational Trauma Quality Improvement Program (2013-2021), including patients who received at least 5 units of PRBCs and 1 unit of FFP within four hours of arrival, was performed. Nonsurvivable injury patterns and pre-existing coagulopathy were excluded. Treatment effects were estimated with propensity score-weighted risk adjustment models, clustering by center. The primary outcome was six-hour mortality. Secondary outcomes were 24-hour and in-hospital mortality. A subanalysis was performed on the severe head-injured, and a sensitivity analysis examined inclusion criteria and additional blood products (platelets and cryoprecipitate). Effect modification was assessed for injury type.

Results: A total of 50,580 patients were included, with 13,818 in the FFP-first approach. Mean age was 39 years, with 77% males, 60% blunt trauma, and a mean Injury Severity Score of 27. Subanalysis included 15,912 patients, and the exposure sensitivity analysis included 27,217 patients. Unadjusted six-hour, 24-hour, and in-hospital mortality for the PRBC-first approach were 9.8%, 15%, and 28%, respectively, compared with 8.9%, 14%, and 27% for the FFP-first approach. A PRBC approach was independently associated with worse six-hour (adjusted Odds Ratio [aOR], 1.10; 95% CI, 1.02-1.18), 24-hour (1.11; 1.05-1.18), and in-hospital mortality (1.06; 1.01-1.11). The subgroup analysis of the PRBC aOR was 1.08 (95% CI, 0.95-1.23). In the exposure sensitivity analysis, the PRBC aOR was 1.02 (95% CI, 0.94-1.09). The blood products analysis was congruent with the main analysis. Effect modification was not present for injury type; however, penetrating mechanism was significantly associated with early death.

Conclusions: Although the effect was modest in magnitude, a FFP-first approach was independently associated with improved survival through hospital discharge. Future prospective or randomized trials are warranted. (J Trauma Acute Care Surg 2026;00:000-000. Copyright © 2026 Wolters Kluwer Health, Inc. All rights reserved.).

Level of evidence: Prognostic and Epidemiological; Level III.

Keywords: Coagulopathy; hemorrhagic; massive transfusion; resuscitation; shock.

PubMed Disclaimer

References

1. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60(suppl 6):S3–S11.
1. Centers for Disease Control and Prevention. WISQARS: Explore Fatal Injury Data Visualization Tool. Accessed April 6, 2023. https://wisqars.cdc.gov/data/explore-data/home
1. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54(6):1127–1130.
1. Association for the Advancement of Blood and Biotherapies. Plasma: Blood Component Card. Accessed July 31, 2025. https://www.aabb.org/docs/default-source/default-document-library/resour…
1. Cannon JW, Khan MA, Raja AS, Cohen MJ, Como JJ, Cotton BA, et al. Damage control resuscitation in patients with severe traumatic hemorrhage: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2017;82(3):605–617.